|
SAMHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.590240E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.916800E-01 |
| Normal-vs-Stage2 |
2.808000E-02 |
| Normal-vs-Stage3 |
1.523370E-01 |
| Normal-vs-Stage4 |
7.249800E-01 |
| Stage1-vs-Stage2 |
2.896200E-02 |
| Stage1-vs-Stage3 |
1.188420E-01 |
| Stage1-vs-Stage4 |
8.194000E-01 |
| Stage2-vs-Stage3 |
2.376000E-01 |
| Stage2-vs-Stage4 |
1.951150E-01 |
| Stage3-vs-Stage4 |
5.466200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.970600E-01 |
| Normal-vs-AfricanAmerican |
1.689780E-01 |
| Normal-vs-Asian |
1.779390E-01 |
| Caucasian-vs-AfricanAmerican |
3.054400E-01 |
| Caucasian-vs-Asian |
2.946600E-01 |
| AfricanAmerican-vs-Asian |
6.311400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.234800E-01 |
| Normal-vs-Female |
4.458200E-02 |
| Male-vs-Female |
9.575600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.725200E-01 |
| Normal-vs-Extreme_Weight |
9.241800E-01 |
| Normal-vs-Obese |
1.462590E-01 |
| Normal-vs-Extreme_Obese |
1.034990E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.192000E-01 |
| Normal_Weight-vs-Obese |
2.605400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.349900E-02 |
| Extreme_Weight-vs-Obese |
6.433900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.864000E-02 |
| Obese-vs-Extreme_Obese |
2.776700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.116400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.194200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.111200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.724000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.897200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.032610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.748380E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.154650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.875200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.765700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.583800E-01 |
| Normal-VS-Type2 PRCC |
2.893000E-01 |
| Normal-VS-KIRP CIMP |
2.909500E-02 |
| Normal-VS-Unclassified PRCC |
5.197900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.702800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.286500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.959800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.785200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.364300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.492400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.899400E-01 |
| Normal-vs-N1 |
7.679700E-02 |
| Normal-vs-N2 |
6.796400E-01 |
| N0-vs-N1 |
3.689600E-01 |
| N0-vs-N2 |
9.219600E-01 |
| N1-vs-N2 |
6.317000E-01 |
|
|
